73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study identifies molecular differences between primary breast cancer and its metastases

Study identifies molecular differences between primary breast cancer and its metastases

by UNC Lineberger Comprehensive Cancer CenterStudy design and global genomic patterns of metastatic breast tumors. a, Cohort description of the AURORA Metastatic Project. b, Diagram of the shared

Study identifies molecular differences between primary breast cancer and its metastases

by UNC Lineberger Comprehensive Cancer CenterStudy design and global genomic patterns of metastatic breast tumors. a, Cohort description of the AURORA Metastatic Project. b, Diagram of the shared
Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman
Drug combo breaks down cancer resistance to immunotherapy

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst

Drug combo breaks down cancer resistance to immunotherapy

by Ecole Polytechnique Federale de LausanneA schematic summary of the study. Credit: Douglas Hanahan (EPFL)Immunotherapy is a way of treating cancer by reprogramming the patient's immune syst
Trials supporting FDA approval of breakthrough drugs examined

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a
New way to target cancer's diversity and evolution

New way to target cancer's diversity and evolution

by Institute of Cancer ResearchCredit: CC0 Public DomainScientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up

New way to target cancer's diversity and evolution

by Institute of Cancer ResearchCredit: CC0 Public DomainScientists have revealed close-up details of a vital molecule involved in the mix and match of genetic information within cells—opening up
New immune system understanding may help doctors target cancer

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang

New immune system understanding may help doctors target cancer

by Garth Sundem,CU Anschutz Medical CampusPaul Norman, PhD. Credit: University of Colorado Cancer CenterYour immune system's natural killer cells recognize and attack two major kinds of dang
Treatment to a T? Taking a 'BiTE' out of lung cancer

Treatment to a T? Taking a 'BiTE' out of lung cancer

by Osaka UniversityThe team measured the T-lymphocyte cytotoxicity against tumor cell lines using a molecule that binds to both T lymphocytes and tumor cell lines. Credit: Osaka UniversityImmune

Treatment to a T? Taking a 'BiTE' out of lung cancer

by Osaka UniversityThe team measured the T-lymphocyte cytotoxicity against tumor cell lines using a molecule that binds to both T lymphocytes and tumor cell lines. Credit: Osaka UniversityImmune
Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re

Team studies association between tumor mutations and meningioma recurrence in Grade I/II disease

by Impact JournalsAdjusted progression-free survival hazard ratios for genes examined. Credit: 2022 Dullea et al.A new research paper titled "Association between tumor mutations and meningioma re
Researchers identified a protein associated with breast cancer

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente
Genetic variation explains racial disparity in esophageal cancer cases

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the
Discovery of hybrid cancer cells reveals how disease spreads

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t
ASCO: undertreatment seen for women with head and neck cancer

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi

ASCO: undertreatment seen for women with head and neck cancer

(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, accordi